LBA3 Nivolumab (NIVO) + platinum-doublet chemotherapy...

Annals of Oncology 2019 / 12 Vol. 30; Iss. Supplement

LBA3 Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 final analysis

Paz-Ares, L, Ciuleanu, T E, Yu, X, Salman, P, Pluzanski, A, Nagrial, A, Havel, L, Kowalyszyn, R, Audigier-Valette, C, Wu, Y-L, Borghaei, H, Hellmann, M D, Brahmer, J, Reck, M, Ramalingam, S, Zhang, L,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz453.004
Date:
December, 2019
File:
PDF, 106 KB
2019
Conversion to is in progress
Conversion to is failed